PCVX

55.3305.19%
JF

Jeff Fairman

Co-Founder & VP of Research

Dr. Jeff Fairman, Ph.D. is Founder of Vaxcyte, Inc. (formerly known as SutroVax, Inc.) since 2013 and serves as its Vice President of Research since December 2013. Dr. Fairman co-founded Juvaris BioTherapeutics Inc., in 2003 and served as its Vice President, Research from February 2002 to September 2011. Dr. Fairman served as Senior Research Director of Juvaris BioTherapeutics, Inc. In 1996, Dr. Fairman began his industrial experience with AmCell Corporation working to develop technologies to isolate fetal cells from maternal blood for cytogenetic analysis. From July 2011 to December 2013, Dr. Fairman served as Vice President, Research at Colby Pharmaceuticals, a biopharmaceutical company. In 1997, Dr. Fairman joined Valentis, Inc., where he managed the assay development group and conducted preclincial efficacy and toxicity studies. Dr. Fairman is a Member of the American Association of Immunologists and the Infectious Diseases Society of America. He is also a consultant on quantitative PCR/RT-PCR and in-situ PCR/RT-PCR at the University of California, Davis, Applied Biosystems and Celera Diagnostics. Most recently, Dr. Fairman served as the Director of Pharmacogenomics Research at Clingenix Inc. where he directed research in the application of pharmacogenomics to clinical development. During his time at Clingenix, Dr. Fairman was inventor on several patents involving the application of technologies. Dr. Fairman is a program Manager and experienced scientist in the use of cationic lipsome-DNA complexes in gene therapy. He is an author of many research publications and review articles in the area of hematopoetic neoplasms. After receiving his Ph.D. in Chemistry from the University of Arkansas in 1992, Dr. Fairman conducted his postdoctoral training at M.D. Anderson Cancer Center specializing in the genetics of leukemia. While at M.D. Anderson his research focused on genetic abnormalities in myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML). Dr. Fairman earned his B.S. degree in chemistry at Northwest Missouri State University and his Ph.D. in chemistry from the University of Arkansas.

Positions